Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
1.
Cell Immunol ; 290(1): 21-9, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24859013

RESUMEN

α-Viniferin is an oligostilbene of trimeric resveratrol and has anticancer activity; however, the molecular mechanism underlying the anti-inflammatory effects of α-viniferin has not been completely elucidated thus far. Therefore, we determined the mechanism by which α-viniferin regulates lipopolysaccharide (LPS)-induced expression of proinflammatory mediators in BV2 microglial cells. Treatment with α-viniferin isolated from Clematis mandshurica decreased LPS-induced production of nitric oxide (NO) and prostaglandin E2 (PGE2). α-Viniferin also downregulated the LPS-induced expression of proinflammatory genes such as iNOS and COX-2 by suppressing the activity of nuclear factor kappa B (NF-κB) via dephosphorylation of Akt/PI3K. Treatment with a specific NF-κB inhibitor, pyrrolidine dithiocarbamate (PDTC), indirectly showed that NF-κB is a crucial transcription factor for expression of these genes in the early stage of inflammation. Additionally, our results indicated that α-viniferin suppresses NO and PGE2 production in the late stage of inflammation through induction of heme oxygenase-1 (HO-1) regulated by nuclear factor erythroid 2-related factor (Nrf2). Taken together, our data indicate that α-viniferin suppresses the expression of proinflammatory genes iNOS and COX-2 in the early stage of inflammation by inhibiting the Akt/PI3K-dependent NF-κB activation and inhibits the production of proinflammatory mediators NO and PGE2 in the late stage by stimulating Nrf2-mediated HO-1 signaling pathway in LPS-stimulated BV2 microglial cells. These results suggest that α-viniferin may be a potential candidate to regulate LPS-induced inflammation.


Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Benzofuranos/farmacología , Ciclooxigenasa 2/biosíntesis , Microglía/inmunología , FN-kappa B/antagonistas & inhibidores , Óxido Nítrico Sintasa de Tipo II/biosíntesis , Animales , Línea Celular , Clematis , Dinoprostona/biosíntesis , Hemo-Oxigenasa 1/biosíntesis , Hemo-Oxigenasa 1/inmunología , Mediadores de Inflamación , Lipopolisacáridos , Proteínas de la Membrana/biosíntesis , Proteínas de la Membrana/inmunología , Ratones , Factor 2 Relacionado con NF-E2/biosíntesis , Factor 2 Relacionado con NF-E2/genética , FN-kappa B/genética , Óxido Nítrico/biosíntesis , Fosfatidilinositol 3-Quinasas/inmunología , Inhibidores de las Quinasa Fosfoinosítidos-3 , Fosforilación , Extractos Vegetales , Raíces de Plantas , Proteínas Proto-Oncogénicas c-akt/antagonistas & inhibidores , Proteínas Proto-Oncogénicas c-akt/inmunología , Pirrolidinas/farmacología , Interferencia de ARN , ARN Interferente Pequeño , Tiocarbamatos/farmacología
2.
Chemosphere ; 326: 138436, 2023 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-36933842

RESUMEN

The renewability and zero carbon emissions of hydrogen make it a promising clean energy resource to meet future energy demands. Owing to its benefits, photocatalytic water-splitting has been extensively investigated for hydrogen production. However, the low efficiency poses a serious challenge to its implementation. Herein, we attempted to synthesize bimetallic transition metal selenides, namely Co/Mo/Se (CMS) photocatalysts, with varying atomic compositions (CMSa, CMSb, and CMSc) and investigated their photocatalytic water splitting efficiencies. The observed hydrogen evolution rates were as follows: 134.88 µmol g-1 min-1 for CoSe2, 145.11 µmol g-1 min-1 for MoSe2, 167.31 µmol g-1 min-1 for CMSa, 195.11 µmol g-1 min-1 for CMSb, and 203.68 µmol g-1 min-1 for CMSc. Hence, we deemed CMSc to be the most potent photocatalytic alternative among the compounds. CMSc was also tested for its efficiency towards degradation of triclosan (TCN), and results substantiated that CMSc succeeded degrading 98% TCN while CMSa and b were able to degrade 80 and 90% TCN respectively-the attained efficiency being exponentially higher than CoSe2 and MoSe2 taken for comparative analysis in addition to complete degradation of the pollutants leaving no harmful intermediaries during the process. Thus, CMSc shall be identified as a highly potential photocatalyst with respect to both environmental and energy applications.


Asunto(s)
Cobalto , Molibdeno , Luz , Agua , Hidrógeno
3.
Biochem Biophys Res Commun ; 422(4): 568-72, 2012 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-22583896

RESUMEN

Peroxisome proliferator-activated receptor-alpha (PPARα) is a nuclear receptor that regulates the expression of genes related to cellular lipid uptake and oxidation. Thus, PPARα agonists may be important in the treatment of hypertriglyceridemia and hepatic steatosis. In this study, we demonstrated that catalposide is a novel natural PPARα agonist, identified from reporter gene assay-based activity screening with approximately 900 natural plant and seaweed extracts. Results of time-resolved fluorescence resonance energy transfer analyses suggested that the compound interacted directly with the ligand-binding domain of PPARα. Cultured hepatocytes stimulated with catalposide exhibited significantly reduced cellular triglyceride concentrations, by 21%, while cellular uptake of fatty acids was increased, by 70% (P<0.05). Quantitative PCR analysis revealed that the increase in cellular fatty acid uptake was due to upregulation of fatty acid transporter protein-4 (+19% vs. the control) in cells stimulated with catalposide. Additionally, expression of genes related to fatty acid oxidation and high-density lipoprotein metabolism were upregulated, while that of genes related to fatty acid synthesis were suppressed. In conclusion, catalposide is hypolipidemic by activation of PPARα via a ligand-mediated mechanism that modulates the expression of in lipid metabolism genes in hepatocytes.


Asunto(s)
Glucósidos/farmacología , Hepatocitos/efectos de los fármacos , Hipertrigliceridemia/metabolismo , Metabolismo de los Lípidos/efectos de los fármacos , PPAR alfa/agonistas , Ácidos Grasos/metabolismo , Transferencia Resonante de Energía de Fluorescencia , Genes Reporteros/efectos de los fármacos , Glucósidos/química , Células Hep G2 , Hepatocitos/química , Hepatocitos/metabolismo , Humanos , Ligandos , Lípidos/análisis
4.
Bioorg Med Chem Lett ; 22(6): 2347-9, 2012 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-22342624

RESUMEN

A new acetylenic acid, (10E,14Z)-9-oxooctadeca-10,14-dien-12-ynoic acid (1), was isolated from the edible mushroom Chanterelle (Cantharellus cibarius), together with a known acetylenic acid, (10E,14Z)-9-hydroxyoctadeca-10,14-dien-12-ynoic acid (2) and their structures were determined through analysis of NMR and mass data. The new acetylenic acid (1) specifically activated peroxisome proliferator-activated receptor (PPAR)-γ with an EC(50) value of 1.88 µM as measured by a reporter gene assay. Expression of PPAR-γ target genes were significantly altered as well, supporting the hypothesis that compound 1 is a PPAR-γ potential agonist that regulates transcription of the PPAR-γ target genes.


Asunto(s)
Agaricales/química , Alquinos/química , Antineoplásicos/química , Ácidos Grasos Insaturados/química , Hipoglucemiantes/química , PPAR gamma/agonistas , Alquinos/aislamiento & purificación , Alquinos/farmacología , Animales , Antineoplásicos/aislamiento & purificación , Antineoplásicos/farmacología , Células CHO , Cromanos/farmacología , Cricetinae , Relación Dosis-Respuesta a Droga , Ácidos Grasos Insaturados/aislamiento & purificación , Ácidos Grasos Insaturados/farmacología , Expresión Génica , Genes Reporteros , Células Hep G2 , Humanos , Hipoglucemiantes/aislamiento & purificación , Hipoglucemiantes/farmacología , Luciferasas/genética , Espectroscopía de Resonancia Magnética , Espectrometría de Masas , PPAR gamma/genética , PPAR gamma/metabolismo , Tiazolidinedionas/farmacología , Transfección , Troglitazona
5.
Bioorg Med Chem Lett ; 22(12): 4094-9, 2012 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-22579484

RESUMEN

The present study reports a novel liver X receptor (LXR) activator, ethyl 2,4,6-trihydroxybenzoate (ETB), isolated from Celtis biondii. Using a reporter gene assay, time-resolved fluorescence resonance energy transfer (TR-FRET), and surface plasmon resonance (SPR) analysis, we showed that ETB directly bound to and stimulated the transcriptional activity of LXR-α and LXR-ß. In macrophages, hepatocytes, and intestinal cells, ETB suppressed cellular cholesterol accumulation in a dose-dependent manner and induced the transcriptional activation of LXR-α/-ß-responsive genes. Notably, ETB did not induce lipogenic gene expression or cellular triglyceride accumulation in hepatocytes. These results suggest that ETB is a dual-LXR modulator that regulates the expression of key genes in cholesterol homeostasis in multiple cells without inducing lipid accumulation in HepG2 cells.


Asunto(s)
Colesterol/metabolismo , Ácido Gálico/análogos & derivados , Hepatocitos/metabolismo , Macrófagos/metabolismo , Receptores Nucleares Huérfanos/agonistas , Animales , Línea Celular , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Transferencia Resonante de Energía de Fluorescencia , Ácido Gálico/aislamiento & purificación , Ácido Gálico/farmacología , Genes Reporteros , Hepatocitos/efectos de los fármacos , Humanos , Metabolismo de los Lípidos/efectos de los fármacos , Receptores X del Hígado , Macrófagos/efectos de los fármacos , Ratones , Especificidad de Órganos , Receptores Nucleares Huérfanos/genética , Resonancia por Plasmón de Superficie , Activación Transcripcional/efectos de los fármacos , Ulmaceae/química
6.
J Nat Prod ; 75(4): 784-8, 2012 Apr 27.
Artículo en Inglés | MEDLINE | ID: mdl-22424300

RESUMEN

Two new polyhydroxylated macrolides, seimatopolides A (1) and B (2), were isolated from an EtOAc extract of Seimatosporium discosioides culture medium. The structures of the new compounds were established on the basis of spectroscopic analysis, including 1D and 2D NMR, and their absolute configurations were determined using the modified Mosher's method. Seimatopolides A (1) and B (2) activated peroxisome proliferator-activated receptor (PPAR)-γ with EC(50) values of 1.15 and 11.05 µM, respectively. The expression of PPAR-γ target genes in HepG2 hepatocytes was significantly altered; in particular, expression of the gluconeogenic genes glucose-6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK) was reduced upon stimulation with 1, supporting the proposal that compound 1 is both a PPAR-γ agonist and a possible therapeutic candidate for treatment of diabetes.


Asunto(s)
Macrólidos/aislamiento & purificación , Macrólidos/farmacología , PPAR gamma/efectos de los fármacos , Glucosa-6-Fosfatasa/genética , Células Hep G2 , Hepatocitos/metabolismo , Humanos , Macrólidos/química , Estructura Molecular , Resonancia Magnética Nuclear Biomolecular , PPAR gamma/genética , Fosfoenolpiruvato Carboxiquinasa (ATP)/genética , ARN/aislamiento & purificación , Estereoisomerismo
7.
Biotechnol Lett ; 34(12): 2213-21, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23011313

RESUMEN

A novel liver X receptor (LXR) modulator, iristectorigenin B isolated from Belamcanda chinensis, stimulated the transcriptional activity of both LXR-α and LXR-ß. In macrophages, iristectorigenin B suppressed cholesterol accumulation in a dose-dependent manner and induced the transcriptional activation of LXR-α/-ß-responsive genes, ATP-binding cassette transporters A1 and G1. It did not induce hepatic lipid accumulation nor the expression of the lipogenesis genes sterol regulatory element-binding protein-1c, fatty acid synthase, and stearoyl-CoA desaturase-1. Iristectorigenin B thus is a dual-LXR agonist that regulates the expression of key genes in cholesterol homeostasis in macrophage cells without inducing hepatic lipid accumulation.


Asunto(s)
Transportadoras de Casetes de Unión a ATP/biosíntesis , Expresión Génica/efectos de los fármacos , Iridaceae/química , Isoflavonas/metabolismo , Lipoproteínas/biosíntesis , Macrófagos/efectos de los fármacos , Receptores Nucleares Huérfanos/agonistas , Transportador 1 de Casete de Unión a ATP , Transportador de Casetes de Unión a ATP, Subfamilia G, Miembro 1 , Animales , Línea Celular , Isoflavonas/química , Isoflavonas/aislamiento & purificación , Receptores X del Hígado , Ratones
8.
Bioorg Med Chem Lett ; 21(19): 5876-80, 2011 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-21855333

RESUMEN

In this study, we confirmed that ursolic acid, a plant triterpenoid, activates peroxisome proliferator-activated receptor (PPAR)-α in vitro. Surface plasmon resonance and time-resolved fluorescence resonance energy transfer analyses do not show direct binding of ursolic acid to the ligand-binding domain of PPAR-α; however, ursolic acid enhances the binding of PPAR-α to the peroxisome proliferator response element in PPAR-α-responsive genes, alters the expression of key genes in lipid metabolism, significantly reducing intracellular triglyceride and cholesterol concentrations in hepatocytes. Thus, ursolic acid is a PPAR-α agonist that regulates the expression of lipid metabolism genes, but it is not a direct ligand of PPAR-α.


Asunto(s)
Hipertrigliceridemia/fisiopatología , Hipolipemiantes/síntesis química , Hipolipemiantes/farmacología , Metabolismo de los Lípidos , Hígado/metabolismo , PPAR alfa/agonistas , Triterpenos/farmacología , Colesterol/análisis , Relación Dosis-Respuesta a Droga , Descubrimiento de Drogas , Evaluación Preclínica de Medicamentos , Ácidos Grasos/metabolismo , Genes Reporteros , Células Hep G2 , Hepatocitos/metabolismo , Humanos , Hipertrigliceridemia/tratamiento farmacológico , Hipolipemiantes/química , Luciferasas/análisis , Terapia Molecular Dirigida , PPAR alfa/genética , Proliferadores de Peroxisomas/metabolismo , Fitoterapia , Unión Proteica , Triglicéridos/análisis , Triterpenos/química , Ácido Ursólico
9.
Bioorg Med Chem Lett ; 20(3): 1162-4, 2010 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-20022495

RESUMEN

Natural o-dihydroxyisoflavone (ODI) derivatives with variable hydroxyl substituent at the aromatic ring of isoflavone and three known isoflavones were isolated from five-year-old Korean fermented soybean paste (Doenjang) and evaluated as potent inhibitors on tyrosinase activity and melanin formation in melan-a cells comparing with other known isoflavones, 7,8,4'-trihydroxyisoflavone (1) and 7,3',4'-trihydroxyisoflavone (2) inhibited tyrosinase by 50% at a concentration of 11.21+/-0.8 microM and 5.23+/-0.6 microM (IC(50)), respectively, whereas, 6,7,4'-trihydroxyisoflavone (3), daidzein (4), glycitein (5) and genistein (6) showed very low inhibition activity. Furthermore, those compounds significantly suppressed the cellular melanin formation by 50% at a concentration of 12.23+/-0.7 microM (1), 7.83+/-0.7 microM (2), and 57.83+/-0.5(6) and show more activity than arbutin. But, compounds 3, 4, and 5 showed lower inhibition activity. This study shows that the position of hydroxyl substituent at the aromatic ring of isoflavone plays an important role in the intracellular regulation of melanin formation in cell-based assay system.


Asunto(s)
Isoflavonas/química , Melaninas/antagonistas & inhibidores , Monofenol Monooxigenasa/antagonistas & inhibidores , Extractos Vegetales/química , Alimentos de Soja , Línea Celular , Células Cultivadas , Fermentación/fisiología , Humanos , Isoflavonas/aislamiento & purificación , Isoflavonas/metabolismo , Corea (Geográfico) , Melaninas/metabolismo , Monofenol Monooxigenasa/metabolismo , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/metabolismo
10.
Sci Rep ; 10(1): 21730, 2020 Dec 10.
Artículo en Inglés | MEDLINE | ID: mdl-33303838

RESUMEN

We report the extraction of silicon via a carbothermal reduction process using a CO2 laser beam as a heat source. The surface of a mixture of silica and carbon black powder became brown after laser beam irradiation for a few tens of seconds, and clear peaks of crystalline silicon were observed by Raman shift measurements, confirming the successful carbothermal reduction of silica. The influence of process parameters, including the laser beam intensity, radiation time, nitrogen gas flow in a reaction chamber, and the molar ratios of silica/carbon black of the mixture, on the carbothermal reduction process is explained in detail.

11.
Br J Nutr ; 100(5): 1011-8, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18377679

RESUMEN

The sap of Acer mono has been called 'bone-benefit-water' in Korea because of its mineral and sugar content. In particular, the calcium concentration of the sap of A. mono is 37.5 times higher than commercial spring water. In the current study, we examined whether A. mono sap could improve or prevent osteoporosis-like symptoms in a mouse model. Male mice (3 weeks old) were fed a low-calcium diet supplemented with 25, 50 or 100 % A. mono sap, commercial spring water or a high calcium-containing solution as a beverage for 7 weeks. There were no differences in weekly weight gain and food intake among all the groups. Mice that were given a low-calcium diet supplemented with commercial spring water developed osteoporosis-like symptoms. To assess the effect of sap on osteoporosis-like symptoms, we examined serum calcium concentration, and femur density and length, and carried out a histological examination. Serum calcium levels were significantly lower in mice that received a low-calcium diet supplemented with commercial spring water (the negative control group), and in the 25 % sap group compared to mice fed a normal diet, but were normal in the 50 and 100 % sap and high-calcium solution groups. Femur density and length were significantly reduced in the negative control and 25 % sap groups. These results indicate that a 50 % sap solution can mitigate osteoporosis-like symptoms induced by a low-calcium diet. We also examined the regulation of expression of calcium-processing genes in the duodenum and kidney. Duodenal TRPV6 and renal calbindin-D9k were up-regulated dose-dependently by sap, and the levels of these factors were higher than those attained in the spring water-treated control. The results demonstrate that the sap of A. mono ameliorates the low bone density induced by a low-calcium diet, most likely by increasing calcium ion absorption.


Asunto(s)
Acer , Osteoporosis/terapia , Fitoterapia/métodos , Estructuras de las Plantas , Animales , Densidad Ósea/efectos de los fármacos , Calcio/sangre , Calcio/metabolismo , Calcio de la Dieta/administración & dosificación , Agua Dulce/química , Expresión Génica/efectos de los fármacos , Corea (Geográfico) , Masculino , Ratones , Ratones Endogámicos ICR , Modelos Animales , Osteoporosis/metabolismo , Hormona Paratiroidea/sangre , Estructuras de las Plantas/química
12.
Exp Anim ; 56(1): 21-8, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17283887

RESUMEN

In this study, we focused on age-dependent changes in intracellular iron deposition in the gerbil hippocampus. At 1 month of age (PM 1), iron reactivity was weak in the gerbil hippocampus. At this time, cells in the polymorphic layer of the dentate gyrus showed weak iron reactivity. At PM 3, iron reactivity in cells had not changed significantly. Thereafter, iron reactivity in the CA1-3 regions and in the dentate gyrus increased with time until PM 18. At PM 24, iron reactivity in all the subfields was similar to that at PM 18. In animals aged PM 18-24, iron positive cells had various shapes, and had processes which contained iron. These results suggest that the increase of iron deposition may be associated with normal aging and that the iron deposition in the aged hippocampus is different according to hippocampal subfields.


Asunto(s)
Envejecimiento/metabolismo , Hipocampo/metabolismo , Hierro/metabolismo , Animales , Giro Dentado/metabolismo , Gerbillinae , Hipocampo/citología , Masculino , Oligodendroglía/metabolismo
13.
Brain Res ; 1106(1): 197-204, 2006 Aug 23.
Artículo en Inglés | MEDLINE | ID: mdl-16814753

RESUMEN

Interlukin-2 (IL-2) is an important cytokine in the brain: IL-2 and its receptors are involved with inflammatory processes. Chronological changes in IL-2 level in serum, and IL-2 and its receptor (IL-2 receptor beta, IL-2Rbeta) immunoreactivities and levels were examined in the hippocampal CA1 region after transient forebrain ischemia in gerbils. IL-2 level in serum significantly decreased 12 h after ischemia/reperfusion. IL-2 immunoreactivity was detected in the somata of pyramidal cells in sham-operated group. At 15 min after ischemia, IL-2 immunoreactivity was shown in non-pyramidal cells as well as pyramidal cells. One day after ischemia, IL-2 immunoreactivity was lowest, and IL-2 immunoreactivity is shown in non-pyramidal cells from 2 days after ischemia. Four days after ischemia, IL-2 immunoreactivity was shown in dying pyramidal cells. IL-2Rbeta immunoreactivity in the sham-operated and 15 min-3 min post-ischemic groups is detected in the cell membrane of pyramidal cells. From 3 h after ischemia, IL-2Rbeta immunoreactivity is found in cytoplasm and nuclei, but not in cell membrane. IL-2Rbeta immunoreactivity decreases from 6 h after ischemia and is shown mainly in non-pyramidal cells from 3 days after ischemia. The data of Western blot analyses for IL-2 and IL-2Rbeta was similar to the immunohistochemical data. IL-2 infusion into cerebrospinal fluid did not protect hippocampal neurons from ischemic damage. These results suggest that IL-2 and IL-2Rbeta show malfunction from 3 h after ischemia, and exogenous IL-2 does not protect ischemic neuronal damage.


Asunto(s)
Isquemia Encefálica/inmunología , Hipocampo/inmunología , Interleucina-2/inmunología , Ataque Isquémico Transitorio/inmunología , Receptores de Interleucina-2/inmunología , Animales , Infarto Encefálico/inmunología , Infarto Encefálico/metabolismo , Infarto Encefálico/fisiopatología , Isquemia Encefálica/metabolismo , Isquemia Encefálica/fisiopatología , Muerte Celular/efectos de los fármacos , Muerte Celular/inmunología , Modelos Animales de Enfermedad , Regulación hacia Abajo/inmunología , Encefalitis/inmunología , Encefalitis/metabolismo , Encefalitis/fisiopatología , Gerbillinae , Hipocampo/metabolismo , Hipocampo/fisiopatología , Inmunohistoquímica , Inyecciones Intraventriculares , Interleucina-2/metabolismo , Interleucina-2/farmacología , Ataque Isquémico Transitorio/metabolismo , Ataque Isquémico Transitorio/fisiopatología , Masculino , Degeneración Nerviosa/inmunología , Degeneración Nerviosa/metabolismo , Degeneración Nerviosa/fisiopatología , Fármacos Neuroprotectores/inmunología , Fármacos Neuroprotectores/metabolismo , Fármacos Neuroprotectores/farmacología , Células Piramidales/efectos de los fármacos , Células Piramidales/inmunología , Células Piramidales/metabolismo , Receptores de Interleucina-2/agonistas , Receptores de Interleucina-2/metabolismo , Factores de Tiempo , Insuficiencia del Tratamiento
14.
Colloids Surf B Biointerfaces ; 52(1): 52-6, 2006 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-16930960

RESUMEN

Chitosan/gelatin (C/G) microcapsules containing triclosan were prepared by a spray drying method. The core material, triclosan (TS) dissolved in octyl salicylate (OS), were emulsified in an aqueous solution containing variable ratios of chitosan/gelatin. The microcapsules were obtained by spray-drying the emulsions. On the scanning electron micrographs, the microcapsules were spherical and exhibited a core and shell morphology. The thermograms of the microcapsules showed no evidence for the melting of TS, suggesting that TS remained dissolved in the cores of the microcapsules and did not exist as a solid crystalline even after dry microcapsules were formed. According to the results of microelectrophoresis study, the point of zero charge of the microcapsules occurred around pH 9.0 and a higher content of chitosan in the microcapsule wall resulted in a higher positive charge of zeta potential. The degree of release of TS and OS from the C/G microcapsules in an aqueous solution of hydroxypropyl-beta-cyclodextrin (HP-beta-CD) was investigated. When chitosan is included in the wall of microcapsules, the degree of release was suppressed. This indicates that chitosan forms a more compact wall than gelatin. On the other hand, TS was released much more than OS. The preferred release of TS is probably due to the higher solubility of TS in the HP-beta-CD solution.


Asunto(s)
Quitosano/química , Gelatina/química , Triclosán/química , Rastreo Diferencial de Calorimetría , Cápsulas/química , Electroforesis , Luz , Microscopía Electrónica de Rastreo , Tamaño de la Partícula , Dispersión de Radiación , Sensibilidad y Especificidad , Solubilidad , Factores de Tiempo
15.
Arch Pharm Res ; 29(12): 1114-8, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17225460

RESUMEN

(+)-Eudesmin [4,8-bis(3,4-dimethoxyphenyl)-3,7-dioxabicyclo[3.3.0]octane] was isolated from the stem bark of Magnolia kobus DC. var. borealis Sarg. and found to have neuritogenic activity. 50 microM (+)-eudesmin induced neurite outgrowth and enhanced nerve growth factor (NGF)-mediated neurite outgrowth from PC12 cells. At this concentration, (+)-eudesmin also enhanced NGF-induced neurite-bearing activity and this activity was partially blocked by various protein kinase inhibitors. These included PD98059, a mitogen-activated protein kinase (MAPK) kinase inhibitor. GF109203X, a protein kinase C (PKC) inhibitor and H89, a protein kinase A (PKA) inhibitor. These results suggest that (+)-eudesmin can induce neurite outgrowth from PC12 cells by stimulating up-stream MAPK, PKC and PKA pathways.


Asunto(s)
Furanos/farmacología , Lignanos/farmacología , Magnolia/química , Neuritas/efectos de los fármacos , Corteza de la Planta/química , Animales , Flavonoides/farmacología , Furanos/antagonistas & inhibidores , Furanos/aislamiento & purificación , Humanos , Indoles/farmacología , Isoquinolinas/farmacología , Lignanos/antagonistas & inhibidores , Lignanos/aislamiento & purificación , Espectroscopía de Resonancia Magnética , Maleimidas/farmacología , Células PC12 , Inhibidores de Proteínas Quinasas/farmacología , Ratas , Sulfonamidas/farmacología
16.
J Agric Food Chem ; 53(4): 969-72, 2005 Feb 23.
Artículo en Inglés | MEDLINE | ID: mdl-15713007

RESUMEN

The insecticidal activity of phytochemicals isolated from the roots of Phryma leptostachya var. asiatica against third instar larvae of Culex pipiens pallens, Aedes aegypti, and Ocheratatos togoi was examined. The two constituents of P. leptostachya var. asiatica roots were identified as the leptostachyol acetate (I) and 8'-acetoxy-2,2',6-trimethoxy-3,4,4',5'-dimethylenedioxyphenyl-7,7'-dioxabicyclo[3.3.0]octane (II) by spectroscopic analysis. Compound I was lethal to C. pipiens pallens, A. aegypti, and O. togoi at 10 ppm. Compound II showed weak or no insecticidal activity against three mosquito species at 10 ppm. The LC(50) values of I against C. pipiens pallens, A. aegypti, and O. togoi were 0.41, 2.1, and 2.3 ppm, respectively. Naturally occurring P. leptostachya var. asiatica root-derived compounds merit further study as potential mosquito larval control agents or lead compounds.


Asunto(s)
Culicidae , Insecticidas , Larva , Lignanos/análisis , Magnoliopsida/química , Raíces de Plantas/química , Aedes , Animales , Culex , Ochlerotatus
17.
Int Immunopharmacol ; 24(1): 14-23, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25445966

RESUMEN

Microglia are main immune cells to exacerbate neural disorders in persistent overactivating. Therefore, it is a good strategy to regulate microglia for the treatment of neural disorders. In the present study, we isolated and characterized a novel compound, 5-O-isoferuloyl-2-deoxy-D-ribono-γ-lacton (5-DRL) from Clematis mandshurica, and evaluated its anti-inflammatory effect in lipopolysaccharide (LPS)-treated BV2 microglial cells. 5-DRL inhibited the expression of LPS-stimulated proinflammatory mediators such as nitric oxide (NO) and prostaglandin E2 (PGE2), as well as their regulatory genes inducible NO syntheses (iNOS) and cyclooxygenase-2 (COX-2). 5-DRL also downregulated the LPS-induced DNA-binding activity of nuclear factor-κB (NF-κB) through suppression of the nuclear translocation of the NF-κB subunits, p65 and p50. Consistent with the inhibition of iNOS and COX-2 via NF-κB activity with 5-DRL, an inhibitor of NF-κB, pyrrolidine dithiocarbamate (PDTC), also led to the suppression of LPS-induced iNOS and COX-2 expression. Additionally, 5-DRL corresponding with antioxidants, N-acetylcysteine (NAC) and glutathione (GSH), remarkably inhibited reactive oxygen species (ROS) generation. Both NAC and GSH, thus attenuated the expression of iNOS and COX-2 by suppressing NF-κB activation, indicating that 5-DRL suppresses LPS-induced iNOS and COX-2 expression through downregulation of the ROS-dependent NF-κB signaling pathway. The present study also indicated that 5-DRL suppresses NO and PGE2 production by inducing heme oxygenase-1 (HO-1) via nuclear factor erythroid 2-related factor 2 (Nrf2). Taken together, the present data indicate that 5-DRL attenuates the production of proinflammatory mediators such as NO and PGE2 as well as their regulatory genes in LPS-stimulated BV2 microglial cells by inhibiting ROS-dependent NF-κB activation and stimulating the Nrf2/HO-1 signal pathway. These data may be implicated in the application of 5-DRL in LPS-stimulated inflammatory disease.


Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Clematis , Microglía/efectos de los fármacos , FN-kappa B/metabolismo , Enfermedades del Sistema Nervioso/tratamiento farmacológico , Fitoterapia , Acetilcisteína/farmacología , Animales , Línea Celular Transformada , Ciclooxigenasa 2/genética , Ciclooxigenasa 2/metabolismo , Dinoprostona/metabolismo , Regulación hacia Abajo/efectos de los fármacos , Hemo-Oxigenasa 1/genética , Hemo-Oxigenasa 1/metabolismo , Lactonas/química , Lactonas/farmacología , Lipopolisacáridos/inmunología , Proteínas de la Membrana/genética , Proteínas de la Membrana/metabolismo , Ratones , Microglía/inmunología , Factor 2 Relacionado con NF-E2/metabolismo , Óxido Nítrico/metabolismo , Óxido Nítrico Sintasa de Tipo II/genética , Óxido Nítrico Sintasa de Tipo II/metabolismo , Raíces de Plantas , Prolina/análogos & derivados , Prolina/farmacología , Especies Reactivas de Oxígeno/metabolismo , Ribosa/análogos & derivados , Ribosa/química , Ribosa/farmacología , Transducción de Señal/efectos de los fármacos , Tiocarbamatos/farmacología
18.
Phytochemistry ; 111: 141-8, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25487308

RESUMEN

Ten isoflavones, cudraisoflavones B-K (1-10), together with 27 known isoflavones, were isolated from the EtOAc soluble extract of fruits of Cudrania tricuspidata. The structures of compounds 1-10 were elucidated on the basis of MS and NMR spectroscopic data, including 2D NMR experiments. Compounds 7-9 and three known (11-13) compounds showed neuroprotective activity against 6-hydroxydopamine induced cell death in human neuroblastoma SH-SY5Y cells, with EC50 values of 0.5-9.2 µM.


Asunto(s)
Frutas/química , Isoflavonas/aislamiento & purificación , Isoflavonas/farmacología , Moraceae/química , Fármacos Neuroprotectores/aislamiento & purificación , Fármacos Neuroprotectores/farmacología , Muerte Celular/efectos de los fármacos , Humanos , Isoflavonas/química , Estructura Molecular , Fármacos Neuroprotectores/química , Resonancia Magnética Nuclear Biomolecular , Oxidopamina/farmacología , Raíces de Plantas/química
19.
Mol Cells ; 16(2): 216-23, 2003 Oct 31.
Artículo en Inglés | MEDLINE | ID: mdl-14651264

RESUMEN

Phagocytosis by macrophages is most important in the initial stages of an immune response. Although RhoA regulates cell adhesion, its roles in the integrin-related association of particles with macrophages and in phagocytosis are not clearly understood. We introduced C3 exoenzyme, a specific inhibitor of Rho, into J774A.1 macrophage cells fused with the 9 amino acid (49-57) transduction domain (RKKRRQRRR) of HIV-1 Tat. The presence of this Tat-C3 vector altered RhoA mobility on non-denaturing gels, indicating that Tat-C3 modified RhoA by ADP-ribosylation. Uptake of (FITC)-conjugated serum-opsonized zymosan particles and adhesion to fibrinogen-coated plates were reduced as was the association of serum-opsonized zymosan particles, and complement C3 and C3bi with the transfected cells. These results suggest that Rho regulates the activity of integrins that are involved in the association of particles with macrophages, phagocytosis, adhesion, and binding of complement C3 and C3bi.


Asunto(s)
ADP Ribosa Transferasas/metabolismo , Toxinas Botulínicas/metabolismo , Macrófagos/enzimología , Fagocitosis/fisiología , Zimosan/inmunología , Proteína de Unión al GTP rhoA/metabolismo , Animales , Adhesión Celular , Células Cultivadas , Clonación Molecular , Fibrinógeno/metabolismo , Productos del Gen tat/genética , Productos del Gen tat/metabolismo , Integrinas/metabolismo , Macrófagos/fisiología , Proteínas Opsoninas/inmunología , Proteínas Opsoninas/fisiología , Zimosan/fisiología
20.
Neurochem Int ; 67: 39-45, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24486459

RESUMEN

α-l-Rhamnopyranosyl-(1→6)-ß-d-glucopyranosyl-3-indolecarbonate (RG3I) is a chemical constituent isolated from the commonly used Asian traditional medicinal plant, Clematis mandshurica; however, no studies have been reported on its anti-inflammatory properties. In the present study, we found that RG3I attenuates the lipopolysaccharide (LPS)-induced DNA-binding activity of nuclear factor-κB (NF-κB) via the dephosphorylation of PI3K/Akt in BV2 microglial cells, leading to a suppression of nitric oxide (NO) and prostaglandin E2 (PGE2) production, along with that of their regulatory genes, inducible NO synthase (iNOS) and cyclooxygenase-2 (Cox-2). Further, the PI3K/Akt inhibitor, LY294002 diminished the expression of LPS-stimulated iNOS and COX-2 genes by suppressing NF-κB activity. Moreover, RG3I significantly inhibited LPS-induced reactive oxygen species (ROS) generation similar to the ROS inhibitors, N-acetylcysteine (NAC) and glutathione (GSH). Notably, NAC and GSH abolished the LPS-induced expression of iNOS and Cox-2 in BV2 microglial cells by inhibiting NF-κB activity. Taken together, our data indicate that RG3I suppresses the production of proinflammatory mediators such as NO and PGE2 as well as their regulatory genes in LPS-stimulated BV2 microglial cells by inhibiting the PI3K/Akt- and ROS-dependent NF-κB signaling pathway, suggesting that RG3I may be a good candidate to regulate LPS-induced inflammatory response.


Asunto(s)
Anticarcinógenos/farmacología , Dinoprostona/biosíntesis , Disacáridos/farmacología , Indoles/farmacología , Lipopolisacáridos/farmacología , Microglía/efectos de los fármacos , Óxido Nítrico/biosíntesis , Transducción de Señal/efectos de los fármacos , Animales , Línea Celular , Cromatografía por Intercambio Iónico , Espectroscopía de Resonancia Magnética , Ratones , Microglía/enzimología , Microglía/metabolismo , FN-kappa B/metabolismo , Fosfatidilinositol 3-Quinasas/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , Especies Reactivas de Oxígeno/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA